Financials
- Market Capitalization 113.43 M
- Employee 152
- Founded 2013
- CEO N/A
- Website www.lenz-tx.com
- Headquarter Delaware, United States
- FIGI BBG00XDH4NZ2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.61
Rapporto prezzo/fatturato
24.15
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3803 | ENGN enGene Therapeutics Inc. - Common Stock | 1.70 USD | -1.73% | -9.09% | -5.56% | -79.76% | 113.93 M USD | ||
| 3804 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 6.64 USD | -9.04% | -18.53% | -43.63% | -55.76% | 113.88 M USD | ||
| 3810 | CBUS Cibus, Inc. - Class A Common Stock | 1.43 USD | -3.38% | -12.27% | -8.92% | -2.05% | 109.29 M USD | ||
| 3812 | COYA Coya Therapeutics, Inc. - Common Stock | 4.71 USD | -2.08% | -3.88% | +7.29% | -20.44% | 110.49 M USD |